News

Fredun Pharmaceuticals has announced the establishment of a new manufacturing facility in Palghar, Maharashtra, marking the addition of its fifth facility.

Fredun Pharmaceuticals has allotted 40,000 equity shares on conversion of warrants on 09 April 2026.

Net profit of Fredun Pharmaceuticals rose 96.62% to Rs 10.48 crore in the quarter ended December 2025 as against Rs 5.33 crore during the previous quarter ended December 2024. Sales rose 57.04% to Rs 159.93 crore in the quarter ended December 2025 as against Rs 101.84 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales159.93101.84 57 OPM %16.4612.98 - PBDT15.788.22 92 PBT14.007.13 96 NP10.485.33 97 Powered by Capital Market - Live News

Fredun Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 9 February 2026.Powered by Capital Market - Live News

Fredun Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 16 February 2026.Powered by Capital Market - Live News